Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Discover the latest content that has just been published on Research Tree
3M delivered a mixed set of results amidst the challenging economic environment with supply chain disruptions, inflation, and slowing growth. The company did manage to surpass the revenue expectations of Wall Street but missed out on meeting earnings expectations. Because of Covid-related disruptions, 3M saw a significant slowing in China and modernizing demand over industrial markets. The company recently announced restructuring its manufacturing operations as it saw the demand trends extend in
Companies: 3M Co (MMM:NYSE)3M Company (MMM:NYS)
Baptista Research
3M delivered a mixed set of results for the last quarter as it failed to meet revenue expectations of Wall Street but managed an earnings beat. Transportation, Electronics, Safety, Industrial, Consumer, and Health Care all experienced organic growth of 3%. Every business segment produced margins higher than 21%, with noteworthy margin growth in the safety, industrial, transportation, and electronics sectors. This is what helped them deliver an earnings beat. The management keeps investing in gro
Apart from being known as one of the most innovative companies in today’s times, 3M also has a strong reputation of successful restructuring and cost management which has helped the industrial conglomerate survive through many challenging business cycles. The company delivered solid quarterly results surpassing Wall Street expectations on all counts while navigating the continued inflationary pressures and supply chain challenges. The company continues to benefit from strong spending discipline,
Companies: 3M Company (MMM:NYS)Mining, Minerals & Metals plc (MMM:LON)
3M had a strong start to 2022 in a challenging global environment. The company performed well in the first quarter while managing supply chain disruptions, inflation, and geopolitical pressures. 3M delivered a 2% organic growth in the quarter along with sequential margin improvement, and strong cash generation. Demand is strong overall, though the global economic outlook has weakened due to challenges in certain end markets, an ever-changing Covid-19 impact, and recent geopolitical events. 3M co
3M recent revenue performance has been strong on account of the healthcare business, particularly the increase in respiratory demand due to the Omicron variant's impact. The company’s organic growth has been slow and it has witnessed an adverse margin impact of supply chain disruptions, inflation, and Covid-19 but its cost control measures have been strong. 3M's selling price actions gained traction in the last quarter with a year-over-year increase of 2.6%. The company has a strong cash positio
3M had a strong fourth quarter, capping off a fairly decent 2021 despite a rapidly changing external environment. Its revenue in the quarter exceeded expectations across the board, including an increase in respiratory demand due to the Omicron variant's impact. The company’s organic growth has been slower than expected, at 1%, down from 6% in the previous quarter, with earnings being boosted by a strong December execution and a lower-than-expected tax rate. It is worth highlighting that 3M saw g
3M reported another solid quarter with a 7.1% top-line growth and a 6.3% increase year-on-year in organic revenues, comfortably surpassing Wall Street expectations. The company saw a high-single-digit growth across all key segments, particularly the core Safety and Industrial segment which grew by 7.2% and the Consumer segment which grew by 8.1%. However, the company continued to face inflationary pressure including higher costs related to polypropylene, ethylene, resins and labor. The global se
3M managed to deliver yet another all-around beat but its outlook for the rest of the year has been disappointing. The industrial conglomerate, known to produce everything from post-its and adhesives to industrial sandpaper and N95 masks saw a recovery in many of its key segments but has been facing strong inflationary pressures. 3M witnessed surging raw material and freight costs which are likely to lower its 2021 margins. Moreover, the company, which is the largest American producer of N95 mas
Research Tree provides access to ongoing research coverage, media content and regulatory news on 3M Company. We currently have 0 research reports from 2 professional analysts.
Companies: CNC RNO MAI IUG CUSN POLB
Cavendish
Companies: Ultimate Products PLC
Shore Capital
Epwin’s FY23 results were robust and management navigated inflationary pressures well. Despite some market headwinds, we have increased our FY24 and FY25 underlying operating profit estimates for the second time this year. Long-term, well-established growth trends imply that Epwin is well-placed to leverage off increasing demand for its energy-efficient and low-maintenance building products. Epwin offers an attractive investment case with the potential for uplifts from additional self-funded M&A
Companies: Epwin Group PLC
Edison
Companies: eEnergy Group PLC
Canaccord Genuity
Companies: James Cropper plc
Tan Delta develops and supplies sensors and systems which use innovative real time oil analysis technology to allow operators of commercial and industrial equipment to cut maintenance costs, improve reliability, and reduce carbon footprint.
Companies: Tan Delta Systems PLC
Zeus Capital
Companies: Mpac Group PLC
Companies: ARV CLA SLP GAL 002466 GGP JAY KOD GRL MKA SVML GEMD ZIOC
SP Angel
Companies: GAL BEM AAU SHG GGP AAL SLI 1SN EEE TECK
Companies: AURA SYA AAL FAR EEE
Companies: Quadrise PLC
1st May 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced Dish of the day Admissions: Delistings: REDX Pharma (REDX.L) has delisted from the AIM Market What’s baking in the oven? ** Potential**** Initial Public Offerings: Reverse Takeovers: 16 April 2024: Electric Guitar (ELEG.L) Concurrent with its Admission to trading on AIM, Electric Guitar is proposing
Companies: TXP CNC RNO MAI ANX IUG CUSN POLB
Hybridan
Norcros’s disposal of Johnson Tiles is the latest strategic activity taken by management to better allocate capital to fit with priorities. Last year it closed its UK adhesives operation. Norcros has a compelling investment case, where its new product development initiatives, market positioning and self-help initiatives allow it to take market share in both the UK and South Africa. Its rating is low at 6.0x FY24e P/E, which is attractive, especially when compared to its yield of 5.4% on its well
Companies: Norcros plc
Norcros has announced the sale of its Johnson Tiles UK business to the current management team for a consideration of £1.0m, with a further modest earnout based on the equity value of the business, both payable in April 2028.
AUCTUS PUBLICATIONS ________________________________________ ADX Energy (ADX AU)C; target price of A$1.00 per share: Important step to unlock Sicily – The Italian ministry has informed ADX that it will be granted the d 363C.R-.AX gas exploration permit in the Sicily Channel. In addition, the Regional Administrative Court of Rome has annulled the Plan for the Sustainable Energy Transition of Eligible Areas that prevented the oil redevelopment, appraisal and exploration activities on the licence.
Companies: PEN EQNR ENI TCFF SEI OKEA GPRK ADX REP AKRBP RHC RHC SOU ITH REP SQZ TRIN SOU I3E ZPHR NOG LNGE TTE PEN ENI EQNR VAR OKEA
Auctus Advisors
Share: